Two New Drug Industry Lawsuits Challenge 340B Contract Pharmacy Access Laws in Kansas, Missouri

Drugmaker Novartis and trade organization PhRMA each recently filed a new lawsuit against separate state 340B contract pharmacy access laws.
A powerful brand name drug industry trade group has filed suit against a Kansas law prohibiting drugmaker 340B contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

J&J Exempts Maryland, Mississippi from Contract Pharmacy Restrictions

Drugmaker J&J announced for the first time that it is exempting certain states from its 340B contract pharmacy restrictions.
Pharmaceutical giant Johnson & Johnson (J&J) is exempting covered entities in Maryland and Mississippi from its contract pharmacy restrictions, marking [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Allows for Immediate 340B Enrollment in Three Southeastern States Due to Hurricane Debby

HRSA has granted 340B enrollment flexibility in certain states as a result of damage from Hurricane Debby.
Eligible providers in Florida, Georgia and South Carolina can now immediately enroll in the 340B program without waiting for the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

VP Pick Tim Walz Signed Multiple 340B Laws in Minnesota, Including Contract Pharmacy Access, But Faced Opposition from Hospitals Over Certain Policies

Tim Walz, who has signed multiple 340B-related laws as governor of Minnesota, is the Democratic pick for vice president.
Minnesota Gov. Tim Walz, Vice President Kamala Harris’ Democratic running mate in the U.S. presidential race, has been a vocal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

More Drugmakers Exempt New States from 340B Contract Pharmacy Restrictions

Sanofi was one of three drug manufacturers to recently update its contract pharmacy restrictions in response to new state laws.
Pharmaceutical manufacturers Sanofi, GlaxoSmithKline (GSK) and Viatris are fully or partially exempting additional states from their 340B contract pharmacy restrictions. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Third Drugmaker Sues Kansas Over Its 340B Contract Pharmacy Access Law

Novartis became the third pharmaceutical manufacturer to sue Kansas over its 340B contract pharmacy access law.
Novartis is now the third drug manufacturer to challenge Kansas’ new law prohibiting drug manufacturers from restricting contract pharmacy access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Maryland, Louisiana AGs Step Up Defense

Lawsuits challenging 340B contract pharmacy access laws recently heated up in Arkansas, Mississippi and Minnesota.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

PhRMA Petitions Supreme Court to Overturn Arkansas’ 340B Contract Pharmacy Access Law

PhRMA petitioned the U.S. Supreme Court to take a case on the constitutionality of Arkansas' 340B contract pharmacy access law.
A powerful drug industry trade group has asked the U.S. Supreme Court to overturn a federal appeals court’s decision to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

PhRMA-Backed Conservative Think Tank Tells State Lawmakers Not to Pass 340B Contract Pharmacy Access Bills During Annual Meeting

Leah Vukmir, a former Republican Wisconsin state lawmaker, told legislators at ALEC's annual meeting not to support 340B contract pharmacy access legislation.
An industry-funded conservative policy group known for delivering model bills to Republican lawmakers recently urged an audience of state legislators [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Column: Three Key Observations from Efforts to Restore 340B Discounts in the States

Ted Slafsky, publisher and CEO of 340B Report, writes about efforts to pass state 340B contract pharmacy access legislation.
After six months of heated battles in the states to restore access to 340B drug discounts in the contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live